Stephen Davis, CEO at ACADIA PHARMACEUTICALS INC (ACAD), sold 11,154 shares at $24.67 ($275K) on 2024-02-26, disclosed to the SEC on 2024-02-27.
Seasonal sale ($275k) by CEO — this insider has traded ACAD in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.67 | 5,577 | $138K | 50.0% |
| 2 | $24.67 | 5,577 | $138K | 50.0% |
| Total | $24.67 avg | 11,154 | $275K | 100% |
| Filing → |
| ACAD | SELL | 2024-04-09 | $950K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $634K | — | Filing → |
| ACAD | SELL | 2024-01-09 | $224K | — | Filing → |